| Previous Section | Index | Home Page |
7 Jan 2010 : Column 614W—continued
A new paragraph 13B(4) is added, so that where any person who (a) is the sponsor of a paediatric clinical trial in the United Kingdom in respect of a medicinal product (i) with a United Kingdom marketing authorisation, but where the trial is not instigated by the marketing authorisation holder; or (ii) without a United Kingdom or Community marketing authorisation, where the trial is not included in a paediatric investigation plan; and (b) fails to submit the results of that trial to the EMEA within the period of six months beginning on the date that the trial ended as required by article 41(2) of the paediatric regulation, he shall be guilty of an offence;
A new paragraph 13B(5) is added, so that where any person who (a) has sponsored a paediatric clinical trial in the United Kingdom in respect of a medicinal product (i) with a United Kingdom marketing authorisation, but who is not the marketing authorisation holder; or (ii) without a United Kingdom or Community marketing authorisation, where the trial is not included in a paediatric investigation plan and ended on or after 26 January 2007 but before 29 December 2008; and (b) fails to submit the results of that trial to the EMEA on or before 29 June 2009 as required by article 41(2) of the paediatric regulation, he shall be guilty of an offence;
A new paragraph 13B(6) is added, so that any holder of a United Kingdom marketing authorisation who (a) has knowledge of a paediatric study in respect of the product to which the authorisation relates that ended on or before 25 January 2007; and (b) fails to submit that paediatric study to the licensing authority on or before 29 June 2009 as required by article 45(1) of the paediatric regulation, shall be guilty of an offence;
A new paragraph 13B(7) is added, so that any holder of a United Kingdom marketing authorisation who (a) sponsors a paediatric study in respect of the product to which the authorisation relates; and (b) fails to submit the results to the licensing authority within a period of six months beginning with the date that the trial ended as required by article 46(1) of the paediatric regulation, shall be guilty of an offence;
A new paragraph 13B(8) is added, so that any holder of a United Kingdom marketing authorisation who (a) has sponsored a paediatric study in respect of the product to which the authorisation relates which ended on or after 26 January 2007 but before 29 December 2008; and (b) fails to submit the results to the licensing authority on or before 29 June 2009 as required by article 46(1) of the paediatric regulation, shall be guilty of an offence.
No criminal offences have been abolished by secondary legislation since 1 May 2008.
Diabetes
Keith Vaz: To ask the Secretary of State for Health (1) what the cost of treating diabetes in children under the age of 16 years was in each of the last five years; [308739]
(2) what the cost of treating diabetes in adults was in each of the last five years. [308749]
Ann Keen: Estimates of national health service expenditure on diabetes are available from the programme budgeting returns. However, the programme budget returns do not contain age-specific data relating to the treatment of diabetes.
The following table shows the estimated gross level expenditure for diabetes from 2004-08 in England. These figures include primary care trust, Department of Health (DH), strategic health authority and special health authority expenditure. It should be noted that these figures do not
include prevention expenditure or general medical services/primary medical services expenditure. This is considerable, but we cannot quantify it separately.
| Diabetes expenditure (£) | DH gross expenditure (£) | Diabetes as a proportion of gross expenditure (Percentage) | |
Diabetes: Young People
Keith Vaz: To ask the Secretary of State for Health (1) how many 16 to 24-year-olds are being treated for diabetes in (a) England, (b) Leicester and (c) the East Midlands; [308747]
(2) how many 16 to 24-year-olds in (a) England, (b) Leicester and (c) the East Midlands have been diagnosed with (i) type 1 diabetes and (ii) type 2 diabetes. [308748]
Ann Keen: The data requested are not collected routinely, as participation in the National Diabetes Audit (NDA) is not mandatory. The NDA does not have 100 per cent. coverage or participation and therefore cannot provide the information required.
Data from "Growing Up with Diabetes: children and young people with diabetes in England" reported that in February 2009 there were 4,917 people aged 16 and 17 in England with diabetes and 331 people aged 16 and 17 in the East Midlands Strategic Health Authority (SHA) with diabetes.
Of the 4,917 people aged 16 and 17 in England with diabetes, 4,629 had type 1 diabetes and 288 had type 2 diabetes. In the East Midlands SHA there were 313 people aged 16 and 17 with type 1 diabetes and 18 people aged 16 and 17 with type 2 diabetes.
This survey did not collect data on people aged 18 and over and data are only available by SHA.
Dietary Supplements: EC Law
Mr. Todd: To ask the Secretary of State for Health if the Food Standards Agency will raise at future meetings with the authorities in Guernsey and Jersey the implementation of the EU (a) Food Supplements Directive and (b) Nutrition and Health Claims Regulation. [309079]
Gillian Merron: The implementation of the Food Supplements Directive and Nutrition and Health Claims Regulation was last raised with the authorities of Guernsey and Jersey in September 2009. No further meetings are currently planned.
Disabled: Social Security Benefits
Mr. Stephen O'Brien: To ask the Secretary of State for Health (1) whether all existing and future claimants of (a) attendance allowance and (b) disability living allowance who are over the age of 65 years will need to agree care plans in order to receive an equivalent level of support; [309116]
(2) whether all (a) existing and (b) future claimants of (i) attendance allowance and (ii) disability living allowance who are over the age of 65 will have the option of continuing to be able to receive their benefit in cash via a direct payment from a future national care service. [309117]
Phil Hope: If disability benefits for older people are reformed as part of the introduction of the National Care Service, people receiving the affected benefits at the time of reform will continue to receive the same level of cash support. We do not anticipate that these people will need to agree a care plan in order to access this cash support.
As we said in the Green Paper, if we were to draw some disability benefits for older people into the new National Care Service, we would create a new offer for individuals with care needs. This support would be delivered in line with the best principles of benefits; a system that is consistent across the country, flexible methods of payment and investment in prevention.
Health Services: Gloucestershire
Mr. Drew: To ask the Secretary of State for Health how much has been spent on healthcare in the Gloucestershire Primary Care Trust area (a) primary, (b) secondary and (c) other health care categories in each year since 1999. [309138]
Mr. Mike O'Brien: The information is not held in the format requested.
Figures on how much has been spent on health care services in the Gloucestershire primary care trust (PCT) area from 2002-03 to 2008-09 are given in the following table. These are the only years for which the information is available by organisation.
| Gloucestershire PCT-purchase of health care 2002-03 to 2008-09 | |||
| £000 | |||
| Primary health care | Secondary health care | Other health care | |
| Notes: 1. The figures represent the total primary, secondary and other health care purchased and provided for the PCT's resident population, with the exception of primary dental and general ophthalmic services since these costs are not directly attributed to PCTs on the basis of a patient's place of residence. 2. 'Other healthcare' as defined in the audited summarisation schedules is taken to include expenditure for national health service trust impairments, plus grants to other bodies for health related capital projects under joint working arrangements. Source: Audited summarisation schedules 2002-03 to 2008-09 | |||
Mr. Drew: To ask the Secretary of State for Health how much (a) Gloucestershire county council and (b) district councils in Gloucestershire were paid by the NHS for joint-funded projects in each year since 1999. [309139]
Mr. Mike O'Brien: The information requested is not collected centrally.
Health Services: Overseas Visitors
Andrew Mackinlay: To ask the Secretary of State for Health whether EU citizens are entitled to free hospital care and treatment in circumstances where admission to hospital is non-elective as the need for admission and treatment was unforeseen prior to the patient's entry into the United Kingdom; and if he will make a statement. [309432]
Gillian Merron: Residents of the European economic area and Switzerland visiting the United Kingdom (UK) are entitled, free of charge, to all necessary national health service hospital treatment.
Under European regulations, where visitors carry a valid European Health Insurance Card the UK can then reclaim the cost of that treatment from the citizen's home member state.
Health Services: Reciprocal Arrangements
Mike Penning: To ask the Secretary of State for Health (1) how much the NHS (a) was entitled to reclaim and (b) has reclaimed for health care carried out on UK citizens in other countries with which the UK has a reciprocal agreement in the last 12-month period for which figures are available; [308380]
(2) how much has been reclaimed by the NHS for healthcare carried out in England in respect of nationals of other countries with which the UK has a reciprocal agreement in the last 12-month period for which figures are available. [308381]
Gillian Merron: The United Kingdom does not claim reimbursement for UK citizens treated in other countries on the basis of bilateral health care agreements, as the costs are incurred in the country that provided the health care, and not in the UK.
Similarly, countries with which the UK has a bilateral health care agreement do not claim reimbursement from the UK for treatment provided in the UK to their citizens, as the costs are incurred in the UK, and not in the citizen's home country.
European regulations provide for the UK to reclaim costs from the European economic area and Switzerland for health care provided to their citizens, and vice versa.
Hospital Wards: Greater London
Mr. Evennett: To ask the Secretary of State for Health how many (a) mixed-sex and (b) single-sex wards there are in South London Healthcare NHS Trust hospitals. [308503]
Ann Keen: The information requested is not collected centrally. Information on the different types of ward may be obtained from the national health service locally.
Ice Skating: Injuries
Mr. Hoyle: To ask the Secretary of State for Health how many people required hospital treatment as a result of ice-skating accidents in (a) Lancashire and (b) each county in the North West in each of the last three years. [308291]
Ann Keen: The information is not available in the format requested. Information for hospital admissions involving ice-skates, skis, roller-skates or skateboards by North West Strategic Health Authority (SHA) and primary care trust (PCT) of residence is shown in the following table:
| Finished admission episodes( 1) for fall involving ice-skates, skis, roller-skates or skateboards( 2) by North West SHA and PCT of residence( 3) , 2006-07 to 2008-09 | |||
| SHA/PCT of residence description | 2006-07 | 2007-08 | 2008-09 |
| Notes: (1) Full time equivalent figures are rounded to the nearest whole number. (2) A supplementary code that indicates the nature of any external cause of injury, poisoning or other adverse effects. Only the first external cause code which is coded within the episode is counted in HES. Cause code used: W02-Fall involving ice-skates, skis, roller-skates or skateboards. (3) The SHA or PCT containing the patient's normal home address. This does not necessarily reflect where the patient was treated as they may have travelled to another SHA/PCT for treatment. Source: The NHS information centre for health and social care. | |||
| Next Section | Index | Home Page |